UK-based medical technology company, Moletest (Scotland) Ltd, is offering primary care professionals the opportunity to reduce the number of dermatology referrals to secondary care with nomela, a screening test for skin lesions suspected of melanoma.
WHY IT MATTERS
GPs and other primary care professionals will be able to use a nomela iPad to take images of the suspect skin lesion, which are...
Miiskin has introduced automatic skin imaging, available in a consumer app, which will enable people to take full-body photographs of their own skin, at home, to make skin cancer self-examinations easier.
The new feature applies a combination of Apple's computer vision and augmented reality technologies to audibly and visually assist the user in taking photos alone and hands-free. The user places...
